Racial Differences in Urine Testing of Febrile Young Children Presenting to Pediatric Hospitals

Sriram Ramgopal1,2, Nichell Tidwell3, Nader Shaikh4

  • 1Division of Emergency Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. sramgopal@luriechildrens.org.

Insights

Black children received less urine testing for urinary tract infections (UTIs) in emergency departments, but this did not lead to more missed diagnoses or revisits. Further research is needed to understand these disparities in pediatric UTI care.

Area of Science:

  • Pediatric Emergency Medicine
  • Infectious Diseases
  • Health Equity

Background:

  • Historical practice guidelines suggested lower urinary tract infection (UTI) risk in Black children.
  • Race-based clinical decisions raise concerns about potential disparities in healthcare.
  • Investigating disparities in diagnostic testing for febrile young children is crucial.

Purpose of the Study:

  • To examine urine testing rates (urinalysis and/or urine culture) among young febrile children in the emergency department (ED) by race/ethnicity.
  • To assess the association between race/ethnicity and UTI diagnosis and 7-day revisits.
  • To identify potential missed diagnoses related to race-based testing variations.

Main Methods:

  • A multicenter retrospective cohort study included 734,730 children aged 2-24 months with fever across 26 US EDs (2009-2019).
  • Longitudinal testing trends were evaluated using a generalized linear mixed-effects model.
  • Associations of race/ethnicity with testing, UTI diagnoses, and revisits were characterized.

Main Results:

  • Black children constituted 24.1% of the cohort and showed lower urine testing rates (23.4%) compared to White (31.7%) and Hispanic (33.9%) children.
  • Black patients had significantly lower adjusted odds of receiving urine testing (OR 0.70; 95% CI 0.69-0.71).
  • Among tested patients, UTI diagnosis rates were 2.4% for Black children versus 3.3% for White children. Return visits within 7 days were slightly higher for Black children who received testing on the index visit (8.5%) compared to those who did not (7.6%).

Conclusions:

  • Black patients experienced lower rates of urine testing and UTI diagnoses in the ED setting.
  • These disparities in testing were not linked to increased rates of missed diagnoses or unscheduled return visits.
  • Further investigation is warranted to understand and address the observed racial disparities in pediatric UTI diagnostic practices.
Abstract

Related Concept Videos

Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
379
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
190
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
22
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
24
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
73
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
35